Moderna Incorporation announced the awardees of its 2024 Australia Fellowship Program
Ernest Moles, Senior Research Officer at Children’s Cancer Institute and Conjoint Senior Lecturer at UNSW Medicine and Health shared a post by Children’s Cancer Institute on LinkedIn, adding:
“Many thanks Craig Rayner FTSE FAHMS FRCP Edin, Claire Borg and all the Moderna team for this exciting opportunity and preparing the video.
I look forward to undertaking this journey together and developing what I truly believe will be a long-lasting partnership with Moderna. Thanks also to our collaborators Pall Thordarson, Matt Dun, Maria Kavallaris AM FAHMS FRSN and team members Zan Dai and Lakshika Keerthirathna your support.
I look forward to catching up with you all soon.”
Quoting Children’s Cancer Institute’s post:
“Moderna Incorporation, today announced the awardees of its 2024 Australia Fellowship Program. The program, in its second year, is dedicated to developing the country’s world-leading health and medical research sector in mRNA medicine and supporting Australian scientists with an interest in advancing mRNA innovation.
We’re thrilled to share that the awardees are Dr. Ernest Moles PhD from Children’s Cancer Institute and Dr. Felix Rizzuto from UNSW.
Dr. Moles‘ research focuses on developing a new RNA-based therapy to treat aggressive brain cancers called high-grade gliomas (HGGs). These cancers are difficult to treat due to their rapid growth and the challenges of delivering current treatments to the brain.
Dr. Moles aims to use cutting-edge mRNA technology to create specialised immune cells (CAR T cells) inside the body to target and destroy cancer cells. This approach could offer the potential for a more efficient, better tolerated, and cost-effective treatment option for patients, with the aim of improving survival and quality of life.
“It is a pleasure to welcome Dr. Moles and Dr. Rizzuto to the Moderna Australia Fellowship Program. Their work reflects the calibre of scientific expertise in Australia, driving forward the potential of mRNA science to address some of the world’s most challenging health issues,” said Michael Azrak, General Manager of Moderna Australia and New Zealand.
We’re incredibly proud of the contribution Dr Ernest Moles has been making in the world of childhood cancer, so please join us in congratulating him on this wonderful recognition of his work.”
Proceed to the video attached to the post.
For more updates, follow OncoDaily.
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023